Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Go back to Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
(NASDAQ: KNSA) Delayed: 79.63 +1.04 (1.32%)
Previous Close $78.59    52 Week High $ 
Open $78.78    52 Week Low $ 
Day High $80.61    P/E N/A 
Day Low $78.36    EPS $ 
Volume 213,444